Literature DB >> 33725263

Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?

Márta L Debreczeni1,2, Zsuzsanna Németh1, Erika Kajdácsi1, Henriette Farkas1,3, László Cervenak4.   

Abstract

In the last few decades, a substantial body of evidence underlined the pivotal role of bradykinin in certain types of angioedema. The formation and breakdown of bradykinin has been studied thoroughly; however, numerous questions remained open regarding the triggering, course, and termination of angioedema attacks. Recently, it became clear that vascular endothelial cells have an integrative role in the regulation of vessel permeability. Apart from bradykinin, a great number of factors of different origin, structure, and mechanism of action are capable of modifying the integrity of vascular endothelium, and thus, may participate in the regulation of angioedema formation. Our aim in this review is to describe the most important permeability factors and the molecular mechanisms how they act on endothelial cells. Based on endothelial cell function, we also attempt to explain some of the challenging findings regarding bradykinin-mediated angioedema, where the function of bradykinin itself cannot account for the pathophysiology. By deciphering the complex scenario of vascular permeability regulation and edema formation, we may gain better scientific tools to be able to predict and treat not only bradykinin-mediated but other types of angioedema as well.
© 2021. The Author(s).

Entities:  

Keywords:  Angioedema; Bradykinin; Endothelial cells; Pathomechanism; Permeability

Mesh:

Substances:

Year:  2021        PMID: 33725263      PMCID: PMC7962090          DOI: 10.1007/s12016-021-08851-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  238 in total

1.  Local bradykinin generation in hereditary angioedema.

Authors:  J Nussberger; M Cugno; M Cicardi; A Agostoni
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

Review 2.  Capillary leak syndrome: etiologies, pathophysiology, and management.

Authors:  Eric Siddall; Minesh Khatri; Jai Radhakrishnan
Journal:  Kidney Int       Date:  2017-03-17       Impact factor: 10.612

Review 3.  Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.

Authors:  Sacha Zeerleder; Marcel Levi
Journal:  Ann Med       Date:  2016-03-26       Impact factor: 4.709

Review 4.  Histaminergic Angioedema.

Authors:  Paula J Busse; Tukisa Smith
Journal:  Immunol Allergy Clin North Am       Date:  2017-05-13       Impact factor: 3.479

Review 5.  Angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  James Brian Byrd; Albert Adam; Nancy J Brown
Journal:  Immunol Allergy Clin North Am       Date:  2006-11       Impact factor: 3.479

Review 6.  The central role of endothelium in hereditary angioedema due to C1 inhibitor deficiency.

Authors:  Maddalena Alessandra Wu; Maria Bova; Silvia Berra; Riccardo Senter; Debora Parolin; Sonia Caccia; Marco Cicardi
Journal:  Int Immunopharmacol       Date:  2020-02-27       Impact factor: 4.932

Review 7.  ACE inhibitor-mediated angioedema.

Authors:  Vincenzo Montinaro; Marco Cicardi
Journal:  Int Immunopharmacol       Date:  2019-12-10       Impact factor: 4.932

Review 8.  The microvascular pathophysiology of chronic venous insufficiency.

Authors:  P F McDonagh
Journal:  Yale J Biol Med       Date:  1993 Jan-Feb

Review 9.  Molecular pathophysiology of cerebral edema.

Authors:  Jesse A Stokum; Volodymyr Gerzanich; J Marc Simard
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-16       Impact factor: 6.200

Review 10.  Hepatic circulation: potential for therapeutic intervention.

Authors:  F Ballet
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

View more
  3 in total

Review 1.  A narrative review on sacubitril/valsartan and ventricular arrhythmias.

Authors:  Zhaoyang Wei; Meiwei Zhang; Qian Zhang; Linan Gong; Xiangyu Wang; Zanzan Wang; Ming Gao; Zhiguo Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

2.  Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway.

Authors:  Huifen Zhou; Yu He; Jiaqi Zhu; Xiaojie Lin; Juan Chen; Chongyu Shao; Haitong Wan; Jiehong Yang
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 3.  Treatment of hereditary angioedema-single or multiple pathways to the rescue.

Authors:  Anna Valerieva; Hilary J Longhurst
Journal:  Front Allergy       Date:  2022-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.